ExodusPoint Capital Management, LP

Position in CRL — Charles River Laboratories International, Inc.

CIK 1736225 NEW YORK, NY

Position in CRL

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$2,495,902

-$5,280,160 QoQ

Shares Held

14,469

-70.9% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ExodusPoint Capital Management, LP holds $77,228,781 across 7 Diagnostics & Research names. CRL ranks #5 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DHR	Danaher Corp /De/	226,876	$43,015,689
2	GH	Guardant Health, Inc.	152,698	$14,104,714
3	A	Agilent Technologies, Inc.	79,881	$9,104,836
4	ADPT	Adaptive Biotechnologies Corp	555,020	$7,703,677
5	CRL	Charles River Laboratories International, Inc. This page	14,469	$2,495,902
6	CSTL	Castle Biosciences Inc	32,608	$800,526
7	NOTVQ	Inotiv, Inc.	12,730	$3,437

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,495,902	14,469	-70.9%	Shares	Sole	2026-05-14
2025-09-30	$7,776,062	49,700	+2411.4%	Shares	Sole	2025-11-14
2024-09-30	$389,803	1,979	-94.9%	Shares	Sole	2024-11-12
2023-12-31	$9,181,303	38,838	-40.4%	Shares	Sole	2024-02-14
2023-09-30	$12,764,961	65,134	+354.3%	Shares	Sole	2023-11-13
2023-06-30	$3,014,144	14,336	-76.1%	Shares	Sole	2023-08-11
2023-03-31	$12,127,363	60,090	+668.5%	Shares	Sole	2023-05-11
2022-12-31	$1,703,760	7,819	+160.9%	Shares	Sole	2023-02-13
2021-12-31	$1,129,209	2,997	-96.9%	Shares	Other	2022-02-11
2021-03-31	$27,876,718	96,183	+739.1%	Shares	Other	2021-05-17
2020-12-31	$2,864,145	11,463	-81.2%	Shares	Sole	2021-02-16
2020-09-30	$13,832,245	61,083	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.